The number of reported worldwide infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was 56.88 million as of November 19, 2020, and this number continues to increase despite restrictions. I will. Given that the virus is new, the medical system is not easily equipped to tackle the outbreak.
Image Credit: Leigh Prather / Shutterstock.com
But the study published this month mBioThe journal of the American Society for Microbiology has produced evidence supporting the early theory that existing vaccination may protect against the more severe symptoms of SARS-CoV-2 infection.
Researchers in this study found that there was an inverse correlation between the level of mumps titer and the severity of symptoms of COVID-19 disease in people vaccinated with mumps-mumps-rubella MMR II vaccine. I found.
Early tips on the association between the MMR vaccine and the severity of COVID-19 symptoms
In September, a team from Medica Sur in Mexico City, led by Dr. Larenas-Linnemann, published the latest findings suggesting the role of the MMR vaccine in reducing the severity of COVID-19 symptoms.
Their treatise is published in a journal Allergies, Researchers explained how individuals vaccinated with the MMR vaccine seemed to develop milder symptoms than expected since the onset of the pandemic.
To follow up on this hypothesis, Jeffrey E. Gold, president of Rescue Me / World Organization, an animal shelter based in Watkinsville, Georgia, and a team of researchers say a possible relationship between MMR vaccines and COVID. Launched a study to investigate. 19 Severity of symptoms.
The level of mumps titer predicts the severity of symptoms
In the current study, 80 individuals were recruited and assigned to one of two groups. The MMR II group consists of 50 subjects who mainly had MMR antibody from the MMRII vaccine, and the comparison group consists of people who have no record of MMRII. People who have obtained MMR antibodies from other sources, such as vaccination and previous infections with measles, mumps, or rubella.
The results of the study showed that the titer of mumps and the severity of COVID-19 symptoms were significantly inversely correlated in the MMRII group. The comparison group did not show such a correlation.
Within the MMR II group, those with asymptomatic functional immunity had high levels of mumps titers (134-300 AU / ml). As the mumps titer level decreased, the symptoms of COVID-19 became more pronounced. Levels below 134 AU / ml were seen in those with mild symptoms, and all those with moderate symptoms showed a titer of 75 AU / ml.
Jeffrey E. Gold, lead author of the study, emphasizes how the results of this study will help develop future strategies to protect people from severe cases of COVID-19. ..
this [the findings] Add to other associations showing that the MMR vaccine may be protective against COVID-19. It may also explain why children have a much lower COVID-19 case rate than adults and have a much lower mortality rate. The majority of children receive the first MMR vaccination around 12 to 15 months of age and the second MMR vaccination at the age of 4 to 6 years. “
Further research needed to reveal the full text
This is the first immunological study to investigate the relationship between the MMR II vaccine and the severity of COVID-19 symptoms, and scientists say MMRII vaccination may protect people from the severity of COVID-19 symptoms. We were able to clarify the evidence supporting the hypothesis that there is.
The significant inverse correlation between mumps titer and the severity of COVID-19 symptoms requires further study. However, given the established safety of the MMR II vaccine, the results show an accessible, cost-effective and safe way to protect people from the serious symptoms of COVID-19 and even hospitalization. I am. The MMR vaccine may provide a way to prevent infection, reduce the spread of the virus, and reduce the severity of symptoms.
However, further research is needed before establishing firm conclusions about the role of MMR in the fight against COVID-19.
Image Credit: Andrii Vodolazhskyi / Shutterstock.com
MMR vaccine can be protected from COVID-19
Source link MMR vaccine can be protected from COVID-19